RSS   Newsletter   Contact   Advertise with us

Quest Diagnostics acquires Blueprint Genetics

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | January 22, 2020
Quest Diagnostics today announced that it has acquired Blueprint Genetics in an all-cash equity transaction.
Quest Diagnostics
Acquisition   Quest Diagnostics
Blueprint Genetics is a leading specialty genetic testing company with deep expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics.

Topics: Quest Diagnostics acquire Blueprint Genetics

Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development.

Financial terms of the transaction were not disclosed.